MusclePharm Announces Launch into Ready-to-Drink Protein Category
MusclePharm Corporation (OTCMKTS: MSLP) announced the launch of its new ready-to-drink whey protein drink line in the summer of 2022. The beverage will feature over 20g of protein, be sugar-free, and will be available in various flavors, expanding MusclePharm's footprint in the growing protein market. CEO Ryan Drexler expressed confidence in the product's potential, supported by a strategic partnership with a premier production firm. This initiative reflects the company's commitment to becoming a leader in the nutrition and beverage sector.
- Launch of ready-to-drink whey protein drinks in summer 2022.
- New product contains over 20g of protein and is sugar-free.
- Strategic partnership with a first-class production company.
- Potential risks include declining consumer spending and changing preferences that may affect product demand.
- Increased competition in the nutrition market could impact market share.
- Health or advertising claims may pose regulatory risks.
Whey Protein Drink Line to Roll Out in the Summer of 2022
LAS VEGAS, March 31, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced it will be expanding into the ready-to-drink protein category with the launch of its new whey protein drink line in the summer of 2022. The new high protein beverage line will be marketed under the leading MusclePharm brand and will contain over 20g of protein, be sugar free and will be available in multiple flavors.
Mr. Ryan Drexler, the Chairman of the Board of Directors and Chief Executive Officer, stated, “I am very excited for our company to enter into the fast-growing ready-to-drink protein category as we build upon our vision to become the leading nutrition and beverage company. We believe our beverage team’s industry expertise and experience, along with partnering with a first-in-class production company, will set this new product apart from the competition and make a huge impact in the category. We could not be happier with the partnership we have formed to bring what we believe will be the best tasting, ready-to-drink protein product on the market this coming summer of 2022.”
About MusclePharm Corporation
MusclePharm is a scientifically-driven, performance lifestyle company that develops, manufactures, markets and distributes branded sports nutrition products and functional energy beverages. Since our incorporation in 2006, we have developed a comprehensive product portfolio, which has fueled the widespread recognition of our brands, MusclePharm and FitMiss. Today, these brands are sold in more than 100 countries globally, supported by our diversified and industry-leading distribution partners. We believe our strong international presence has allowed us to attract a larger and more engaged social media audience than our competitive peers. Our global reach to a large and engaged customer base enables us to achieve The MusclePharm Promise of helping professional athletes and everyday active individuals reach their maximum potential with the most scientifically advanced, safe and nutritious sports supplementation products possible.
Forward-Looking Statements
This communication contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, expectations, estimates, forecasts and projections. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “intends,” “predicts,” “potential,” or “continue” or other comparable terminology. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, risks relating to consumer spending that may decline or that U.S. and global macroeconomic conditions may worsen resulting in reduced demand for the Company’s products, risks relating to changes in consumer preferences away from the Company’s offerings, risks relating to the effectiveness and efficiency of the Company’s advertising campaigns and marketing expenditures, including existing brands and the launch of new brands, which may not result in increased revenue or generate sufficient levels of brand name and program awareness, risks if the Company becomes subject to health or advertising related claims from its customers, competitors or governmental and regulatory bodies, and risks relating to increased competition from other nutrition providers. As a result of these various risks, our actual outcomes and results may differ materially from those expressed in these forward-looking statements.
This list of risks, uncertainties and other factors is not complete. We discuss some of these matters more fully, as well as certain risk factors that could affect our business, financial condition, results of operations, and prospects, in reports we file from time-to-time with the Securities Exchange Commission, which are available to readers at www.sec.gov. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the results of any revisions to the forward-looking statements made in this press release.
Contact:
John Mills, Managing Partner
ICR, Inc.
646-277-1254
John.Mills@icrinc.com
FAQ
What is the new product being launched by MusclePharm in 2022?
When will MusclePharm's ready-to-drink protein line be available?
What are the potential risks associated with MusclePharm's new product launch?
What is MusclePharm's strategy for the beverage market?
What is the stock symbol for MusclePharm?
